1. Home
  2. PRCT vs AIP Comparison

PRCT vs AIP Comparison

Compare PRCT & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$21.48

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Arteris Inc.

AIP

Arteris Inc.

HOLD

Current Price

$43.68

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCT
AIP
Founded
2009
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PRCT
AIP
Price
$21.48
$43.68
Analyst Decision
Buy
Strong Buy
Analyst Count
11
3
Target Price
$35.44
$16.83
AVG Volume (30 Days)
1.4M
941.9K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1.71
4.65
EPS
N/A
N/A
Revenue
$308,054,000.00
$70,579,000.00
Revenue This Year
$31.34
$30.24
Revenue Next Year
$24.52
$19.50
P/E Ratio
N/A
N/A
Revenue Growth
37.22
22.27
52 Week Low
$19.35
$8.10
52 Week High
$62.17
$44.94

Technical Indicators

Market Signals
Indicator
PRCT
AIP
Relative Strength Index (RSI) 34.90 69.14
Support Level $19.35 $13.77
Resistance Level $29.27 N/A
Average True Range (ATR) 1.72 2.93
MACD -0.83 0.43
Stochastic Oscillator 11.58 93.62

Price Performance

Historical Comparison
PRCT
AIP

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.

Share on Social Networks: